Biotechnology - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

151 to 173 of 173 results

Panacea Biotech inaugurates new cancer drug facility in India

28-03-2012

Indian health care management company Panacea Biotec says that it has inaugurated a new state-of-the-art…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPanacea Biotec

Pharming in deal with Hyupjin for Ruconest in South Korea

27-03-2012

Dutch biotech firm Pharming Group (NYSE Euronext: PHARM) has entered into an agreement with Seoul-based…

Asia-PacificBiotechnologyHyupjin CorpLicensingPharmingRare diseasesRhucinRuconest

Anaphore buys Chinese firm RuiYi for GPCR biologics platform

23-03-2012

Privately-held US company Anaphore says it has acquired Shanghai, China-based RuiYi, bringing the company…

AnaphoreAsia-PacificBiotechnologyMergers & AcquisitionsRuiYi

New IP legislation will encourage medical research in Australia, says trade group

20-03-2012

New legislation overhauling the Australian patent system will encourage medical research and bring Australia…

Asia-PacificBiotechnologyLegalPatentsPharmaceuticalResearch

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Apexigen licenses MAb to Gansu Duyiwei for China

12-03-2012

Privately-held US biopharma firm Apexigen has entered into a collaboration to grant an exclusive license…

ApexigenAsia-PacificBiotechnologyGansu DuyiweiLicensingOncology

AusBiotech sets out stall on R&D tax incentive discussion paper

07-02-2012

Australian trade group AusBiotech has lodged a submission in response to the “Discussion Paper:…

Asia-PacificBiotechnologyFinancialResearch

Immuron joins academia for C. Difficile therapeutics

31-01-2012

Australian biotechnology firm Immuron (ASX: IMC) has entered into a collaboration agreement with Australia’s…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyImmuronResearch

Overview of biologic regulations in India

26-01-2012

Currently, all biologics in India, including innovative and copy biologics are approved as new drugs,…

Asia-PacificBiotechnologyGenericsRegulation

A new year and good news is rolling in already, says AusBiotech

25-01-2012

Last year ended on a high for Australian biotechnology industry policy - with the R&D Tax Incentive up…

Asia-PacificBiotechnologyFinancialLicensing

Japanese approval for Regnite and Ranmark

18-01-2012

Japanese drug major Astellas Pharma (TYO: 4503) and USA-based XenoPort (Nasdaq: XNPT) revealed yesterday…

AmgenAsia-PacificAstellas PharmaAstraZenecaBiotechnologyDaiichi SankyodenosumabFinancialNeurologicalOncologyPharmaceuticalRanmarkRegniteRegulationXenoPort

Investment in medicines highest in PHARMAC history

15-12-2011

A surge in the medicines budget over the past three years, combined with New Zealand’s health regulatory…

Asia-PacificBiotechnologyFinancialPharmaceuticalPricingRegulation

Cuba and China sign deals to boost biotechnology cooperation

28-11-2011

Cuba and China have reached agreement to strengthen cooperation on biotechnology, said Cuban Science…

Asia-PacificBiotechnologyPoliticsResearchSouth America

SK biopharma in licensing deal with China’s Medicilon for depression/bipolar drug candidate

02-11-2011

South Korean biotech firm SK biopharmaceuticals says it has entered into an R&D agreement with Medicilon,…

Asia-PacificBiotechnologyLicensingMedicilonNeurologicalPharmaceuticalSK biopharmaceuticals

AusBiotech and PwC update on the state of Australia’ biotechnology sector

26-10-2011

According to the latest update on Australia’s life sciences and biotechnology sector from trade…

Asia-PacificBiotechnologyFinancial

Australian coalition government announces A$55 million commitment to biotechnology

18-10-2011

Australia’s Minister for Technology, Gordon Rich-Phillips this week released a new A$55 million…

Asia-PacificBiotechnologyFinancialPoliticsResearch

Sinovac awarded contract to supply Anflu flu vaccine to Beijing CDC

16-10-2011

Chinese biopharmaceuticals company Sinovac Biotech (Nasdaq: SVA) saw its share price jump 12% to $2.49…

AnfluAsia-PacificBiotechnologyMarkets & MarketingSinovacVaccines

Merck Serono and Ono Pharma collaborate on investigational oral MS drug and cancer vaccine

04-10-2011

Merck Serono, the biotech unit of Germany’s Merck KGaA (MRK: DR), has set out plans to collaborate…

Asia-PacificBiotechnologyGlobalLicensingMerck KGaAMerck SeronoNeurologicalOncologyPharmaceuticalResearchStimuvax

Australian Senate Committee rejects ban on gene patents

22-09-2011

Australia’s pharma and biotech industries breathed a sigh of relief, when a Private Members Bill…

Asia-PacificBiotechnologyPatentsPharmaceutical

Japan’s Toyobo to increase capacity for injectables, eyeing biosimilars

04-09-2011

Japanese conglomerate Toyobo (TYOO: 3101) has outlined plans for its biosciences segment, which includes…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPharmaceuticalToyobo

151 to 173 of 173 results

Back to top